When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
LLY - Lilly's Cyramza shows positive effect in first-line lung cancer
Eli Lilly and Company
Results from a Phase 3 clinical trial, RELAY, evaluating Eli Lilly's (NYSE:LLY) CYRAMZA (ramucirumab) for the first-line treatment of patients with EGFR-positive metastatic non-small cell lung cancer (NSCLC) showed a treatment benefit.
More news on: Eli Lilly and Company, Roche Holding AG, Astellas Pharma Inc., Healthcare stocks news,